Hepatitis C Virus Infection: Clinical Trials

102 trials for Hepatitis C Virus Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

72 completed, 17 unknown, 5 terminated, 3 recruiting. 33 Phase 3, 31 Phase 2, 10 Not applicable, 9 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 333Completed 30, Active not recruiting 1, Terminated 1, Unknown 1
Phase 231Completed 27, Terminated 2, Unknown 1, Withdrawn 1
Not applicable10Unknown 5, Completed 4, Recruiting 1
Phase 19Completed 6, Terminated 1, Unknown 1, Withdrawn 1
Phase 43Completed 1, Not yet recruiting 1, Unknown 1

Follow Hepatitis C Virus Infection: new trials by email Literature Review of Hepatitis C Virus Infection trials Research Report on Hepatitis C Virus Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy
ACCESS+ strategy Epclusa 400/100 Oral Tablet, ACCESS+ Strategy Vosevi 400/100/100 Oral Tablet, Standard Strategy Vosevi 400/100/100 Oral Tablet - Hepatitis C Virus Infection
Phase 4Not yet recruitingANRS, Emerging Infectious Diseases5762025-09-012025-08-01
Hepatitis C Tracker Study
GPS tracker device - Hepatitis C Virus Infection
Not applicableRecruitingUniversity of Southern California1242025-08-082025-08-29
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Bemnifosbuvir-Ruzasvir, Sofosbuvir-Velpatasvir - HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic
Phase 3Active not recruitingAtea Pharmaceuticals, Inc.8802025-06-022026-06-29
Screening, Treatment, and Eradication of Hep C
Hepatitis C Virus Screening - Hepatitis C Virus Infection
Not yet recruitingLiver Institute PLLC1121362024-09-012024-08-27
Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia
Does not apply - Hepatitis C Virus Infection
UnknownAsociación Colombiana de Hepatología2052024-05-202024-06-18
Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development
Hepatitis C Virus Infection
RecruitingCentro di Riferimento Oncologico - Aviano10002024-05-132024-12-05
Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia
rapid diagnostic test HCV Ab Plus Rapid test - Hepatitis C Virus Infection
UnknownAsociación Colombiana de Hepatología256692023-12-162024-06-10
Early Detection of HCV in Injection Drug Users
Hepatitis C antibody (anti-HCV) test, Hepatitis C RNA test and genotype test - Hepatitis C Virus Infection
RecruitingInstitute of Health Information and Statistics of the Czech Republic30002023-12-152025-06-29
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
Contact the patient - Hepatitis C Virus Infection
CompletedUniversitair Ziekenhuis Brussel6002023-07-062025-08-12
Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)
Anti-HCV antibody and HCV core antigen testing - Hepatitis C Virus Infection
UnknownHuashan Hospital200002023-06-262023-07-17
Digital Community to Improve Health in Rural Areas
Virtual Community Intervention, Standard of Care - HIV Infections, Hepatitis C Virus Infection
Not applicableCompletedUniversity of Pennsylvania5112023-06-122026-03-19
Implementing HCV Treatment for High-risk Populations in Austin, Texas
Simplified Hepatitis C Virus (HCV) Treatment Protocol - Hepatitis C Virus Infection
Not applicableUnknownUniversity of Texas at Austin642022-09-292023-04-06
Pharmacist-led Hepatitis C Management
Pharmacist-Led care, Standard of Care (Hepatology) - Hepatitis C Virus Infection
Phase 4UnknownUniversity Health Network, Toronto1082022-04-132022-04-27
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
CARES-HCV - Hepatitis C Virus Infection, Colorectal Cancer
CompletedH. Lee Moffitt Cancer Center and Research Institute392021-11-012023-01-23
Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects
AT-777, Placebo, AT-527 - Hepatitis C, Hepatitis C, Chronic
Phase 1 / Phase 2WithdrawnAtea Pharmaceuticals, Inc.2021-10-012022-06-08
Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection
Vosevi 400/100/100 Oral Tablet - Hepatitis C Virus Infection, Treatment Side Effects
UnknownNational Taiwan University Hospital1002021-10-012021-11-01
Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men
Behavioural intervention, HCV RNA home-based test - Hepatitis C Virus Infection
Not applicableUnknownPublic Health Service of Amsterdam2582021-09-142024-08-02
Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study
Assess the effectiveness and safety of DAAs in patients with IBD., Evaluate the interaction of DAAs with IBD drugs, particularly immunosuppressants and/or biologics., Assessment of the impact of DAAs on the course of IBD. - Inflammatory Bowel Diseases, Hepatitis C Virus Infection
CompletedHospital Mutua de Terrassa792021-03-122022-07-11
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy
Hepatitis C Virus Infection, Hepatitis C Virus Infection, Response to Therapy of
UnknownNational Taiwan University Hospital3002021-02-092021-02-26
HCV Reinfection in HD Patients Achieving SVR
Hepatitis C Virus Infection, Hepatitis C Virus Infection, Response to Therapy of
UnknownNational Taiwan University Hospital3502021-02-012021-02-24

Showing 20 of 102. Sign in to see all of them.

Narrower conditions

Hepatitis C (102)  ·  Hepatitis C, Chronic (12)  ·  Fibrosis (8)  ·  Liver Diseases (6)  ·  Virus Diseases (4)  ·  Acquired Immunodeficiency Syndrome (3)  ·  Infections (3)  ·  RNA Virus Infections (3)  ·  Reinfection (3)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Carcinoma, Hepatocellular (2)  ·  Communicable Diseases (2)  ·  Digestive System Diseases (2)  ·  HIV Infections (2)  ·  Hepatitis (2)

Broader conditions

Blood-Borne Infections (102)  ·  Flaviviridae Infections (101)  ·  Communicable Diseases (100)  ·  Digestive System Diseases (100)  ·  Hepatitis (100)  ·  Hepatitis, Viral, Human (100)  ·  Infections (99)  ·  RNA Virus Infections (99)  ·  Virus Diseases (98)  ·  Liver Diseases (96)  ·  Pathologic Processes (27)  ·  Pathological Conditions, Signs and Symptoms (27)  ·  Disease Attributes (17)  ·  Chronic Disease (12)  ·  Hepatitis, Chronic (12)

Interventions

sofosbuvir-velpatasvir drug combination (26)  ·  ledipasvir, sofosbuvir drug combination (16)  ·  Ribavirin (14)  ·  Sofosbuvir (13)  ·  sofosbuvir velpatasvir voxilaprevir drug combination (8)  ·  daclatasvir (4)  ·  asunaprevir (3)  ·  glecaprevir (3)  ·  glecaprevir and pibrentasvir (3)  ·  pibrentasvir (3)  ·  voxilaprevir (3)  ·  8-cyclohexyl-N-((dimethylamino)sulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)cycloprop(d)indolo(2,1-a)(2)benzazepine-5-carboxamide (2)  ·  AT-511 (2)  ·  Simeprevir (2)  ·  Standard of Care (2)

Sponsors

Gilead Sciences (46)  ·  AbbVie (5)  ·  Bristol-Myers Squibb (4)  ·  Atea Pharmaceuticals, Inc. (3)  ·  National Taiwan University Hospital (3)  ·  Asociación Colombiana de Hepatología (2)  ·  Beni-Suef University (2)  ·  Foundation for Innovative New Diagnostics, Switzerland (2)  ·  Ginkgopharma CO., LTD (2)  ·  Janssen Infectious Diseases BVBA (2)  ·  University of British Columbia (2)  ·  University of La Laguna (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  AbbVie (prior sponsor, Abbott) (1)  ·  Ain Shams University (1)

Countries

United States (38)  ·  Canada (16)  ·  United Kingdom (16)  ·  Germany (15)  ·  New Zealand (14)  ·  Italy (13)  ·  Puerto Rico (13)  ·  France (12)  ·  Australia (11)  ·  Spain (10)  ·  Belgium (9)  ·  Taiwan (8)  ·  Japan (7)  ·  China (6)  ·  Russia (5)

Top investigators

Chen-Hua Liu, MD (3)  ·  Brian Conway, MD (2)  ·  John McNally, PhD (2)  ·  Manuel Hernandez-Guerra, MD (2)  ·  Mohammed Abdel-Gabbar, Ass. Prof (2)  ·  Xuegang Wu (2)  ·  Alberto Sanchez-Fueyo, MD (1)  ·  Anesa Mulabecirovic (1)

Results publications

PMID 27847279, PMID 36740893, PMID 26575258, PMID 30529905, PMID 30977945, PMID 17133492, PMID 25531997, PMID 26569658, PMID 26571066, PMID 26743093, PMID 26799692, PMID 27237429, PMID 27486033, PMID 27486034, PMID 27842383, PMID 27919899, PMID 27959735, PMID 27997679, PMID 28369210, PMID 28390869, PMID 28404069, PMID 28412293, PMID 28535298, PMID 28543053, PMID 28564569, PMID 28957984, PMID 29063860, PMID 29091342, PMID 29174546, PMID 29177645, PMID 29193603, PMID 29666174, PMID 29866893, PMID 29958855, PMID 30012435, PMID 30070726, PMID 30324144, PMID 30499360, PMID 30555048, PMID 30653562, PMID 30868245, PMID 30923816, PMID 31216086, PMID 31220349, PMID 31222783, PMID 31568620, PMID 33493697, PMID 34227402, PMID 34864948, PMID 35149641

NIH funding

2014 (8), 2015 (7), 2016 (6), 2019 (2), 2009 (1), 2017 (1), 2018 (1)